Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey.
Çelen MK, Ertürk Şengel B, Kaya Ş, Demirtürk N, Azap A, Pullukçu H, Eroğlu E, Yıldırım F, Barut HŞ, Zerdali E, Sağmak Tartar A, Mete AÖ, Şahin AM, Mutay Suntur B, Sarı ND, Yılmaz E, Candevir A, Şimşek F, İnan D, Akhan S, Asan A, Günal Ö, Ural O, Parlak M, Çabalak M, Nazik S, Hızel K, Kınıklı S, Beştepe Dursun Z, Batırel A, Mermutluoğlu Ç. Çelen MK, et al. Among authors: kinikli s. J Infect Dev Ctries. 2024 Mar 31;18(3):441-449. doi: 10.3855/jidc.17910. J Infect Dev Ctries. 2024. PMID: 38635621 Free article.
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, Pullukçu H, Batum Ö, Şimşek Yavuz S, Turhan Ö, Yıldırmak MT, Köksal İ, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Çelik İ, Bayındır Y, Karaoğlan İ, Yılmaz A, Özkul A, Gür H, Unal S; CoronaVac Study Group. Tanriover MD, et al. Lancet. 2021 Jul 17;398(10296):213-222. doi: 10.1016/S0140-6736(21)01429-X. Epub 2021 Jul 8. Lancet. 2021. PMID: 34246358 Free PMC article. Clinical Trial.
Relationship between chest computed tomography findings and clinical conditions of coronavirus disease (COVID-19): A multicentre experience.
Yılmaz Demirci N, Uğraş Dikmen A, Taşçı C, Doğan D, Arslan Y, Öcal N, Taşar M, Bozlar U, Artuk C, Yılmaz G, Karacaer Z, Avcı İY, Tuncer Ertem G, Erdinç FŞ, Kınıklı S, Altun Demircan Ş, Ergün E, Nercis Koşar P, Karakoç AE, Gökçek A, Aloğlu M, Gülgösteren S, Atikcan Ş, Akçay Ş, Erol Ç, Hekimoğlu K, Cerit MN, Erbaş G, Özger HS, Bozdayı G, Şenol E, Yurdakul AS, Yılmaz A. Yılmaz Demirci N, et al. Among authors: kinikli s. Int J Clin Pract. 2021 Sep;75(9):e14459. doi: 10.1111/ijcp.14459. Epub 2021 Jun 22. Int J Clin Pract. 2021. PMID: 34105857
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
Demirtürk N, Aygen B, Çelik İ, Mıstık R, Akhan S, Barut Ş, Ural O, Batırel A, Şimşek F, Ersöz G, İnan D, Kınıklı S, Türker N, Bilgin H, Gürbüz Y, Tülek N, Tarakçı H, Yıldız O, Türkoğlu E, Kamalak Güzel D, Şimşek S, Tuna N, Aktuğ Demir N, Çağatay A, Çetinkaya RA, Karakeçili F, Hakyemez İN, Tuncer Ertem G, Örmen B, Korkmaz P, Yıldız U, Kuruüzüm Z, Şener A, Arslan Özel S, Öztürk S, Suer K, Çelen MK, Konya P, Asan A, Saltoğlu N, Doğan N. Demirtürk N, et al. Among authors: kinikli s. Turk J Gastroenterol. 2021 Feb;32(2):155-163. doi: 10.5152/tjg.2020.19569. Turk J Gastroenterol. 2021. PMID: 33960939 Free PMC article.
The Effects of Antimicrobial Resistance and the Compatibility of Initial Antibiotic Treatment on Clinical Outcomes in Patients With Diabetic Foot Infection.
Saltoglu N, Surme S, Ezirmik E, Kadanali A, Kurt AF, Sahin Ozdemir M, Ak O, Altay FA, Acar A, Cakar ZS, Tulek N, Kinikli S; KLİMİK Society, Diabetic Foot Study Group. Saltoglu N, et al. Among authors: kinikli s. Int J Low Extrem Wounds. 2023 Jun;22(2):283-290. doi: 10.1177/15347346211004141. Epub 2021 Apr 15. Int J Low Extrem Wounds. 2023. PMID: 33856261
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience.
Aygen B, Demirtürk N, Yıldız O, Çelen MK, Çelik İ, Barut Ş, Ural O, Batırel A, Mıstık R, Şimşek F, Asan A, Ersöz G, Türker N, Bilgin H, Kınıklı S, Karakeçili F, Zararsız G, Turkish Society Of Clinical Microbiology And Infectious Diseases TSGFVHOT. Aygen B, et al. Among authors: kinikli s. Turk J Gastroenterol. 2020 Apr;31(4):305-317. doi: 10.5152/tjg.2020.19197. Turk J Gastroenterol. 2020. PMID: 32412901 Free PMC article.
44 results